Cargando…
GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy—study protocol
INTRODUCTION: Prostate cancer is the third most important cancer in terms of mortality in men. No standard local treatment exists for patients with an intraprostatic recurrence after radiotherapy. Stereotatic body radiotherapy (SBRT) could be a curative treatment for local recurrence. The phase I/II...
Autores principales: | Pasquier, David, Le Deley, Marie-Cécile, Tresch, Emmanuelle, Cormier, Luc, Duterque, Martine, Nenan, Soazig, Lartigau, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686998/ https://www.ncbi.nlm.nih.gov/pubmed/31377694 http://dx.doi.org/10.1136/bmjopen-2018-026666 |
Ejemplares similares
-
Invited commentary on GETUG-AFU 16
por: Lee, W. Robert
Publicado: (2016) -
Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022) -
Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
por: Cozzi, Salvatore, et al.
Publicado: (2023) -
Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey
por: Vilotte, F., et al.
Publicado: (2022) -
Prostate Stereotactic Ablative Radiation Therapy Using Volumetric Modulated Arc Therapy to Dominant Intraprostatic Lesions()
por: Murray, Louise J., et al.
Publicado: (2014)